Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023
ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023
Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023
Bridgford Foods Corporation (BRID) is expected to report for Q1 2024
Stitch Fix Inc. (SFIX) is expected to report $-0.21 for Q2 2024
Midwest Energy Emissions Corp (MEEC) is expected to report $-0.01 for Q4 2023
Akoya BioSciences Inc. (AKYA) is expected to report $-0.27 for Q4 2023
Eliem Therapeutics Inc (ELYM) is expected to report for quarter end 2023-12-31
Gamer Pakistan Inc. (GPAK) is expected to report for Q4 2023
Inhibitor Therapeutics Inc (INTI) is expected to report for Q4 2023
Global Ship Lease Inc New Class A (GSL) is expected to report $2.34 for Q4 2023
Greenpro Capital Corp. (GRNQ) is expected to report for Q4 2023
Vicarious Surgical Inc. Class A (RBOT) is expected to report $-0.12 for Q4 2023
SAB Biotherapeutics Inc. (SABS) is expected to report $-0.64 for Q4 2023
SUIC Worldwide Holdings Ltd (SUIC) is expected to report for Q4 2023
Grom Social Enterprises Inc. (GROM) is expected to report for Q4 2023
Saipem Spa (SAPMF) is expected to report for Q4 2023
Fresnillo Plc (FNLPF) is expected to report for Q4 2023
Boundary Gold & Copper Mng Ltd. (PRZFF) is expected to report for quarter end 2023-11-30
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023
Zalando SE ADR (ZLNDY) is expected to report for Q4 2023
Cross Timbers Royalty Trust (CRT) is expected to report for Q4 2023
Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares) (AVAL) is expected to report $0.05 for Q4 2023
Abacus Life Inc. (ABL) is expected to report for Q4 2023
Crawford & Company (CRD.B) is expected to report $0.2 for Q4 2023
Kolibri Global Energy Inc. (KGEI) is expected to report $0.12 for Q4 2023
TC Bancshares Inc. (TCBC) is expected to report for Q4 2023
Verde Clean Fuels Inc. (VGAS) is expected to report for Q4 2023
Capstone Green Energy Corporation (CGRNQ) is expected to report for quarter end 2023-12-31
Annexon Inc. (ANNX) is expected to report $-0.48 for Q4 2023
Spectral AI Inc. (MDAI) is expected to report for Q4 2023
Apogee Therapeutics Inc. (APGE) is expected to report $-0.45 for Q4 2023
Calavo Growers Inc. (CVGW) is expected to report for Q1 2024
Oramed Pharmaceuticals Inc. (ORMP) is expected to report $-0.12 for Q4 2023
Cara Therapeutics Inc. (CARA) is expected to report $-0.57 for Q4 2023
Coherus BioSciences Inc. (CHRS) is expected to report $-0.33 for Q4 2023
Sea Limited American Depositary Shares each representing one Class A (SE) is expected to report $-0.29 for Q4 2023
Sagimet Biosciences Inc. (SGMT) is expected to report $-0.62 for Q4 2023
Nxu Inc. (NXU) is expected to report for Q4 2023
Endo International plc (ENDPQ) is expected to report for quarter end 2023-12-31
vTv Therapeutics Inc. (VTVT) is expected to report for quarter end 2023-12-31
NanoVibronix Inc. (NAOV) is expected to report for Q4 2023
AeroVironment Inc. (AVAV) is expected to report $0.32 for Q3 2024
GitLab Inc. (GTLB) is expected to report $-0.19 for Q4 2024
Maris-Tech Ltd. (MTEK) is expected to report for quarter end 2023-12-31
Azul S.A. American Depositary Shares (each representing three preferred shares) (AZUL) is expected to report $-0.22 for Q4 2023
Conduit Pharmaceuticals Inc. (CDT) is expected to report for quarter end 2023-12-31
United Health Products Inc (UEEC) is expected to report for Q4 2023
OptimumBank Holdings Inc. (OPHC) is expected to report for quarter end 2023-12-31
ContextLogic Inc. (WISH) is expected to report for Q4 2023
Crawford & Company (CRD.A) is expected to report for quarter end 2023-12-31
Viant Technology Inc. (DSP) is expected to report $-0.2 for Q4 2023
Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023
Daseke Inc. (DSKE) is expected to report $-0.31 for Q4 2023
Perfect Corp. Class A (PERF) is expected to report $-0.01 for Q4 2023
Resonate Blends Inc (KOAN) is expected to report for Q4 2023
GlobeStar Therapeutics Corp (GSTC) is expected to report for quarter end 2023-12-31
Intensity Therapeutics Inc. (INTS) is expected to report for quarter end 2023-12-31
SEMrush Holdings Inc. Class A (SEMR) is expected to report $0.01 for Q4 2023
Rallybio Corporation (RLYB) is expected to report $-0.44 for Q4 2023
Silo Pharma Inc. (SILO) is expected to report for Q4 2023
UOL Group Limited ADR - Level I (UOLGY) is expected to report for quarter end 2023-12-31
Sohu.com Limited (SOHU) is expected to report $-0.41 for Q4 2023
Volcon Inc. (VLCN) is expected to report for Q4 2023
Shinhan Financial Group Co Ltd American Depositary Shares (SHG) is expected to report $0.67 for Q4 2023
Orchard Therapeutics plc (ORTX) is expected to report $-2.1 for Q4 2023
Science 37 Holdings Inc. (SNCE) is expected to report for Q4 2023
Drilling Tools International Corporation (DTI) is expected to report $0.15 for Q4 2023
GameSquare Holdings Inc. (GAME) is expected to report $-0.02 for Q4 2023
Cardio Diagnostics Holdings Inc. (CDIO) is expected to report $-0.13 for Q4 2023
Vivos Inc (RDGL) is expected to report for Q4 2023
GD Culture Group Limited (GDC) is expected to report for Q4 2023
Future FinTech Group Inc. (FTFT) is expected to report for Q4 2023
Gungnir Resources Inc (ASWRF) is expected to report for quarter end 2023-12-31
PHI Group Inc. (PHIL) is expected to report for Q2 2024
Nektar Therapeutics (NKTR) is expected to report $-0.2 for Q4 2023
Allakos Inc. (ALLK) is expected to report $-0.53 for Q4 2023
BioRestorative Therapies Inc (BRTX) is expected to report $-0.65 for Q4 2023
Ekso Bionics Holdings Inc. (EKSO) is expected to report $-0.11 for Q4 2023
Mesoblast Limited (MESO) is expected to report for Q2 2024
CISO Global, Inc (CISO) is expected to report for Q4 2023
Tenax Therapeutics Inc. (TENX) is expected to report $-8.15 for Q4 2023
LENSAR Inc. (LNSR) is expected to report for quarter end 2023-12-31
Kansas City Life Insurance Co (KCLI) is expected to report for quarter end 2023-12-31
Hepion Pharmaceuticals Inc. (HEPA) is expected to report $-2.63 for Q4 2023
BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023
Li-Cycle Holdings Corp. (LICY) is expected to report $-0.13 for Q4 2023
Passage Bio Inc. (PASG) is expected to report $-0.41 for Q4 2023
RayzeBio Inc. (RYZB) is expected to report $-0.38 for Q4 2023
INNOVATE Corp. (VATE) is expected to report for quarter end 2023-12-31
Biloxi Marsh LDS Corp (BLMC) is expected to report for quarter end 2023-12-31
GBT Technologies Inc (GTCH) is expected to report for Q4 2023
Manuka Inc (MNKA) is expected to report for Q4 2023
Pasithea Therapeutics Corp. (KTTA) is expected to report for Q4 2023
La Rosa Holdings Corp. (LRHC) is expected to report for Q4 2023
Zivo Bioscience Inc. (ZIVO) is expected to report for Q4 2023
China Health Industries Holdings Inc (CHHE) is expected to report for Q2 2024
Orchestra BioMed Holdings Inc Com (OBIO) is expected to report $-0.4 for Q4 2023
Intuitive Machines Inc. (LUNR) is expected to report $-0.12 for Q4 2023
Paymentus Holdings Inc. Class A (PAY) is expected to report $0.05 for Q4 2023
Gaia Inc. (GAIA) is expected to report for quarter end 2023-12-31
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31
Adaptimmune Therapeutics plc (ADAP) is expected to report $-0.12 for Q4 2023
Entrada Therapeutics Inc. (TRDA) is expected to report $-0.07 for Q4 2023
60 Degrees Pharmaceuticals Inc. (SXTP) is expected to report $-0.27 for Q4 2023
Knightscope Inc. (KSCP) is expected to report for Q4 2023
Stoke Therapeutics Inc. (STOK) is expected to report $-0.62 for Q4 2023
CervoMed Inc. (CRVO) is expected to report $-0.95 for Q4 2023
Royale Energy Funds Inc (ROYL) is expected to report for Q4 2023
International Stem Cell Corporation (ISCO) is expected to report for Q4 2023
Cyclacel Pharmaceuticals Inc. (CYCC) is expected to report $-6.35 for Q4 2023
hopTo Inc (HPTO) is expected to report for Q4 2023
ViewRay Inc. (VRAYQ) is expected to report for quarter end 2023-12-31
Cosan S.A. ADS (CSAN) is expected to report $0.18 for Q4 2023
Kaya Holdings (KAYS) is expected to report for Q4 2023
Eos Energy Enterprises Inc. (EOSE) is expected to report $-0.22 for Q4 2023
NuZee Inc. (NUZE) is expected to report for quarter end 2023-12-31
Precigen Inc. (PGEN) is expected to report $-0.08 for Q4 2023
Ocular Therapeutix Inc. (OCUL) is expected to report $-0.28 for Q4 2023
Monarch Cement Co. (MCEM) is expected to report for Q4 2023
Waitr Holdings Inc. (ASAP) is expected to report for Q4 2023
Allurion Technologies Inc. (ALUR) is expected to report $-0.51 for Q4 2023
Bitcoin Depot Inc Com (BTM) is expected to report $-0.08 for Q4 2023
Stellus Capital Investment Corporation (SCM) is expected to report $0.46 for Q4 2023
Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023
Northwest Pipe Company (NWPX) is expected to report $0.42 for Q4 2023
Webco Industries Inc. (WEBC) is expected to report for Q2 2024
Guided Therapeutics Inc (GTHP) is expected to report for Q4 2023
Modiv Industrial Inc. Class C (MDV) is expected to report $0.38 for Q4 2023
WVS Financial Corp. (WVFC) is expected to report for Q2 2024
Schaeffler AG Bearer Preference Shares (SCFLF) is expected to report for Q4 2023
NCS Multistage Holdings Inc. (NCSM) is expected to report for Q4 2023
Advantage Energy Ltd (AAVVF) is expected to report for Q4 2023
Hugoton Royalty Trust (HGTXU) is expected to report for Q4 2023
Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31
SRM Entertainment Inc. (SRM) is expected to report for Q4 2023